Zejula-Avastin Combo Treating Advanced Cancer Patients in Phase 2 Trial
News
Zejula (niraparib) given in combination with Avastin (bevacizumab) shows promising safety and efficacy at delaying disease progression in women with advanced ovarian cancer who had responded to a first-line platinum-based chemotherapy ... Read more